1. At a Glance – The Heart Surgeon Just Bought a British Hospital Chain
₹37,337 Cr market cap. ₹1,827 stock price. P/E 45.2. ROE 24.2%. ROCE 20.8%. And Q3 FY26 revenue at ₹21,512 Mn (₹2,151 Cr) — up a spicy 61.2% YoY.
Welcome to the operating theatre of Narayana Hrudayalaya Ltd, where robotic cardiac surgeries are rising 35% QoQ… but PAT just dropped 33.9% YoY to ₹1,281 Mn.
The stock is down 10.6% in 3 months. Promoter holding dipped slightly to 63.27%. Debt stands at ₹2,340 Cr. Price to book? A premium 9.2×.
And just when you thought this was a simple hospital chain — they went shopping in the UK for GBP 188.78 Mn. Because why just do bypass surgeries when you can bypass geography?
This quarter is not boring. It’s not even stable. It’s a transformation quarter.
So the real question is — are we looking at a healthcare compounding machine… or a surgeon who just swallowed too big a pill?
Let’s scrub in.
2. Introduction – From Bengaluru to Birmingham
Healthcare in India usually means long queues, insurance confusion, and doctors who type faster than you speak.
But Narayana Health built its reputation on affordable cardiac care and operational efficiency. Founded by the Shetty family, it grew from a Bengaluru heart hospital into a 55-facility network spanning India, Cayman Islands, and now… the UK.
As of Jan 2026:
- 5,933 operational beds
- 6,245 total capacity beds
- 20,500 staff
- 18 owned/operated hospitals in India
- 13 facilities in the UK
- 2 hospitals in Cayman Islands
This is no longer a “South India hospital chain.” It’s becoming a cross-continental healthcare platform.
Q3 FY26 is the first quarter where UK numbers (post Nov 6, 2025 acquisition) show up in consolidated results.
Revenue? Exploded.
Margins? Compressed.
PAT? Took a hit due to one-time acquisition cost (₹757 Mn) and new labour code impact (₹509 Mn).
Classic expansion quarter syndrome.
But here’s the twist: India operations still look solid. Cayman revenue grew 70% YoY. UK has begun contributing.
The question now becomes strategic — can they integrate UK without damaging the India margin machine?
Or is this the moment
